In human genetic studies, microglia have been shown to have high expression of numerous AD risk genes, and in recent investigations using tau mouse models, depleting microglia effectively reduced tau seeding activity [6, 7], curbed neuroinflammation, and mitigated tau-related neurodegeneration [8, 9]. This evidence concerns the gene MAPT and Alzheimer disease.